Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age
NCT04748601 is registered in ClinicalTrials.gov with Upsher-Smith Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age
- Lead sponsor
- Upsher-Smith Laboratories
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- February 19, 2021
- Completion date
- September 30, 2026
- Enrollment
- 132 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.